Mercado mundial de reactivos y dispositivos de inmunoensayo: tendencias de la industria y pronóstico hasta 2031

Análisis y tamaño del mercado de reactivos y dispositivos de inmunoensayo

El mercado de reactivos y dispositivos para inmunoensayos es el resultado de la integración continua de tecnologías avanzadas, como la automatización y la miniaturización, para mejorar la eficiencia y la precisión en los procesos de diagnóstico. Estas innovaciones agilizan el flujo de trabajo en los laboratorios, reducen los tiempos de respuesta y aumentan la precisión de las pruebas de inmunoensayos. El compromiso de la industria con los avances tecnológicos mejora las capacidades de diagnóstico y contribuye a la creciente adopción de estos reactivos y dispositivos en diversos entornos de atención médica en todo el mundo.

Data Bridge Market Research analiza que se espera que el mercado global de reactivos y dispositivos de inmunoensayo, que fue de USD 44,49,219.95 millones en 2023, alcance los USD 67,76,551.81 millones para 2031, a una CAGR del 5.4% durante el período de pronóstico de 2024 a 2031. Además de los conocimientos sobre escenarios de mercado como valor de mercado, tasa de crecimiento, segmentación, cobertura geográfica y actores principales, los informes de mercado seleccionados por Data Bridge Market Research también incluyen análisis de expertos en profundidad, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado de reactivos y dispositivos de inmunoensayo

Market Definition

The immunoassay reagents and devices market refers to the industry that produces components and tools used in immunoassay techniques for detecting and measuring specific substances, such as antibodies or antigens, in biological samples. These reagents include antibodies, antigens, enzymes, and other biomolecules essential for the immunoassay process. Key players in the market continually innovate and develop new reagents and devices, fostering growth.

Global Immunoassay Reagents and Devices Market Dynamics

Drivers

• Increasing Demand for Diagnostics

The rising prevalence of infectious and chronic diseases worldwide has led to a growing demand for accurate and efficient diagnostic tools. Immunoassay reagents and devices play a crucial role in diagnosing various conditions, contributing to the market's expansion as healthcare systems focus on early detection and monitoring of diseases.

• Increasing Aging Population  

The increasing aging population worldwide is a key demographic trend impacting market dynamics. As people age, there is a rising demand for healthcare services, particularly in the monitoring and diagnosis of age-related diseases. This trend has spurred a notable increase in the need for immunoassay-based diagnostics, which play a crucial role in detecting and managing various health conditions prevalent among the elderly. The immunoassay technology, known for its accuracy and sensitivity, is adept at identifying biomarkers associated with age-related ailments, contributing to effective disease management.

Opportunities

• Point-of-Care Testing

The increasing demand for timely and efficient healthcare solutions, point-of-care testing allows for on-the-spot testing, minimizing the need for centralized laboratories. This trend is driven by the growing prevalence of infectious diseases and chronic conditions, emphasizing the importance of quick and reliable diagnostic results. The immunoassay reagents and devices market is poised to benefit from the adoption of POCT, as it offers healthcare professionals the ability to make informed decisions at the patient's bedside, enhancing patient care and treatment outcomes. This shift towards decentralized testing reflects a key market advantage, addressing the need for accessible and immediate diagnostic solutions on a global scale.

• Biomarker Discovery

Biomarker discovery is a crucial aspect of medical research that involves identifying specific molecules, known as biomarkers, in the body that indicate the presence or progression of a disease. Immunoassay reagents and devices play a vital role in detecting and measuring these biomarkers, aiding in early disease diagnosis and monitoring. The market's growth is driven by the increasing demand for advanced diagnostic tools, rising prevalence of chronic diseases, and the emphasis on personalized medicine. As biomarker discovery continues to advance, the global immunoassay reagents and devices market is positioned for substantial expansion, offering innovative solutions for precise and early disease detection.

Restraints/Challenges

• High Costs

The expenses involved in research, development, and production of immunoassay reagents and devices contribute to elevated costs. This, in turn, hampers market accessibility for both manufacturers and consumers. The intricate nature of immunoassay technology demands sophisticated instrumentation and specialized reagents, further adding to the financial burden. High production costs may limit the affordability of these diagnostic tools, restricting their widespread adoption.

• Regulatory Challenges

The immunoassay industry is subject to rigorous regulatory scrutiny and approval processes. Meeting the stringent standards set by health authorities can be time-consuming and resource-intensive for manufacturers. Delays in regulatory approvals may impede the timely introduction of new products to the market, affecting innovation and competitiveness within the industry.

This global immunoassay reagents and devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global immunoassay reagents and devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In November 2022, Getein unveiled the MAGICL 6000 CLIA analyzer at MEDICA 2022, catering to mid to high-workflow laboratories with its compact design. This innovative one-step CLIA solution provides optimal efficiency for such laboratory settings
• In November 2022, LumiraDx launched a rapid microfluidic immunoassay HbA1c test across Europe, parts of the Middle East, Asia, Latin America, and Africa. This expansion signifies a strategic move to make this diagnostic tool widely available in diverse regions
• In April 2022, Bio-Techne Corporation and Cygnus Technologies introduced the Simple Plex HEK 293 HCP 3G assay for automated process impurity detection on the Ella immunoassay platform. Addressing the vital need for impurity clearance in Gene and Cell Therapy applications, this assay facilitates accurate quantification of host cell proteins (HCP) throughout viral production phases, aligning with regulatory criteria for ensuring product purity
• In February 2022, Hycor Biomedical Inc secured additional FDA 510(k) clearance for the NOVEOS Immunoassay Analyzer, a chemiluminescent diagnostic tool designed to measure analyte concentrations in human samples. The device, specializing in allergy diagnosis, enhances the capabilities of in-vitro diagnostic equipment
• In January 2021, Abbott's Panbio COVID-19 Ag Rapid Test Device received the CE Mark for asymptomatic SARS-CoV-2 virus diagnosis. This test, equipped with self-swabbing capabilities, offers an efficient and accessible solution for detecting the virus in diverse settings

Global Immunoassay Reagents and Devices Market Scope

The global immunoassay reagents and devices market is segmented on the basis of product, platform, technique, specimen type, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Reagents and Kits
• Analyzers

Platform                                                                                               

• Chemiluminescence Immunoassays
• Fluorescence Immunoassays
• Enzyme Immunoassay
• Radioimmunoassays
• Others

Technique

• Enzyme-Linked Immunosorbent Assays
• Rapid Tests
• Enzyme-Linked Immunospot
• Western Blotting
• Immuno-PCR
• Other Techniques

Specimen Type

• Blood
• Urine
• Saliva
• Others

Application

• Infectious Diseases
• Oncology And Endocrinology
• Bone and Mineral Disorders
• Cardiology
• Hematology and Blood Screening
• Autoimmune Disorders
• Toxicology
• Neonatal Screening
• Other Applications

End User

• Hospitals
• Clinical Laboratories
• Pharmaceutical And Biotechnology Companies
• Blood Banks
• Research and Academic Laboratories
• Others

Global Immunoassay Reagents and Devices Market Regional Analysis/Insights

The global immunoassay reagents and devices market are analysed and market size insights and trends are provided by country, product, platform, technique, specimen type, application and end user as referenced above.

The countries covered in the global immunoassay reagents and devices market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates in the global immunoassay reagents and devices market, both in terms of market share and revenue. This dominance is expected to persist from 2024 to 2031, driven by heightened investments in research and development, growing government initiatives, and enhanced healthcare infrastructure across the region. The increased focus on these factors contributes to the flourishing market presence of North America in the field of immunoassay technologies.

The Asia-Pacific is expected to experience the most rapid growth in the global immunoassay reagents and devices market from 2024 to 2031. This can be attributed to heightened government investments in the healthcare sector and a surge in technological advancements. The region's commitment to healthcare initiatives further propels its position as a key player in driving market expansion during the forecast period.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Crecimiento de la infraestructura de atención de salud Base instalada y penetración de nuevas tecnologías

El mercado global de reactivos y dispositivos de inmunoensayo también le proporciona un análisis detallado del mercado para cada país: el crecimiento del gasto en atención médica para equipos de capital, la base instalada de diferentes tipos de productos para el mercado global de reactivos y dispositivos de inmunoensayo, el impacto de la tecnología mediante curvas de línea de vida y los cambios en los escenarios regulatorios de la atención médica y su impacto en el mercado global de reactivos y dispositivos de inmunoensayo. Los datos están disponibles para el período histórico 2016-2021.

Análisis del panorama competitivo y de la cuota de mercado global de reactivos y dispositivos de inmunoensayo

El panorama competitivo del mercado global de reactivos y dispositivos de inmunoensayo proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y la variedad de productos, el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado global de reactivos y dispositivos de inmunoensayo.

Algunos de los principales actores que operan en el mercado global de reactivos y dispositivos de inmunoensayo son:

• F. Hoffmann-La Roche Ltd (Suiza)
• Siemens (Alemania)
• Randox Laboratories Ltd. (Reino Unido)
• Abbott (Estados Unidos)
• Laboratorios Bio-Rad, Inc. (Estados Unidos)
• Merck KGaA (Alemania)
• Beckman Coulter, Inc. (Estados Unidos)
• BIOMÉRIEUX (Francia)
• Thermo Fisher Scientific Inc. (Estados Unidos)
• BD (Estados Unidos)
• Mindray Bio-Medical Electronics Co., Ltd. (China)
• DiaSorin SpA (Italia)
• Diagnóstico clínico ortopédico (EE. UU.)
• QIAGEN (Alemania)
• Corporación QuidelOrtho (Estados Unidos)
• BioCheck (Estados Unidos)
• Bio-Techne (Estados Unidos)
• PerkinElmer Inc. (Estados Unidos)
• Agilent Technologies, Inc. (Estados Unidos)
• MESO SCALE DIAGNOSTICS, LLC (EE. UU.)

SKU-1726